Health Conditions For Medical Marijuana in Minnesota Archives

The world’s view on marijuana appears to be rapidly changing. Marijuana was thought of as solely a recreational drug only a few years ago. It was basically slid into a role as something to use only to escape the world and get high. It has been classified by the DEA as drug in Schedule 1, with no medical value. It was put into the same category as heroin and LSD. More recently, medical professionals have been starting to recognize the research on cannaboids and the beneficial compounds marijuana holds. The public perception of marijuana is starting turn in its favor.

Last week there were three main events that advanced the growing acceptance of the medicinal value of marijuana. The first was that the American Academy of Pediatrics (AAP) came out in favor of re-classifying marijuana to a Schedule 2 drug, just like other narcotics like morphine or Percocet. This would change the federal status from being illegal on all fronts to being considered a drug, and thus legal to study and to be prescribed for certain medical conditions. Currently, with its Schedule 1 status, doing adequate medical research is extremely difficult, stifling the development of medical knowledge and its usage. Preliminary research does show medical value of various cannaboids for seizures, nausea, cancer and pain. However, which cannaboids of the about 100 known compounds work best with the least amount of risks is poorly understood. Furthermore, we do not know if it is a combination of compounds or if a specific delivery mechanism is necessary.

The new US Surgeon General, Dr. Vivek Murthy, M.D. has also joined the chorus. This week he indicated that he supported reclassifying marijuana to Schedule 2 drug. He also reported that cannaboids did have medical value in certain conditions. Again, the reclassification would allow widespread research and development of cannaboids for their medicinal value.

Marijuana in Minnesota

In Minnesota, medical marijuana appears to be slowly moving forward. The growers of marijuana have been selected and several locations for dispensaries have been chosen. It still will be limited in use, and it will not be available for the use in pain management, at least in the early stages. The state will investigate marijuana’s potential benefits for chronic pain suffers during the first year medicinal marijuana is available. Furthermore, several Indian tribes are considering whether they will make medical marijuana legal and available on their reservations. The rules that apply on Indian reservations will be up to the individual tribes since they act as sovereign nations with their own laws.

The value of cannaboids to treat many conditions appears to be more positive, and the research is catching up. Changes in the legal drug status hopefully will become reality soon, and the knowledge of how to use these compounds as medicine will become more solid. For now, it is still illegal to use marijuana, and most physicians, due to legal constraints and lack of definite knowledge of risks, do not actively recommend its use.

As Minnesota moves toward the end of 2014, the medical marijuana laws are starting to take effect. Minnesota’s laws have very strict rules with regards to the use of marijuana for medicinal purposes. It is restricted to only certain conditions and only two forms will be available; Pill or oil for vaporization.

Health care practitioners will have a limited role in the Minnesota medical marijuana program. Patients will be strictly controlled and monitored, and only limited conditions have been approved for treatment. Furthermore, all medical marijuana will be controlled and distributed only through specific state controlled distribution sites.

Medical Conditions For Marijuana in Minnesota

Minnesota has legalized cannabis for only seven medical conditions. The conditions are cancer, glaucoma, AIDS, Tourette’s syndrome, ALS, epilepsy and Crohn’s disease. Medical marijuana is also available to individuals with a terminal illness with a life expectancy of less than a year who are experiencing pain, suffering, nausea or wasting. The Department of Health can add new medical conditions to the list, but the Minnesota legislature has the power to veto any additions. The first condition that should be added before any other condition is intractable pain. The Commissioner of Health would need to provide a report to the legislature on the reasons why it would qualify for cannabis use in order to add chronic or intractable pain to the list of approved conditions.

Medical providers in Minnesota are not required to participate in the marijuana program. However, a provider who does participate has multiple responsibilities under the law. A participating provider who certifies a patient must continue to follow the patient once they start the program. A patient cannot have a casual relationship with the provider; they must undergo a comprehensive evaluation, including history and physical exam, development of a treatment strategy, determination of a qualifying condition, and be counseled on the risks and benefits of medical marijuana, knowing full-well that this is an experimental treatment. The patient must give informed consent to all aspects of management and be followed regularly to determine if the treatment is effective. Furthermore, their medical records must be shared for research and tracking purposes with the Department of Health. The patient must be re-certified for the program annually.

Medical Marijuana Dosage

The cannabis derivative and dose will be determined by the pharmacists that are associated with the program. They will provide instructions to the distribution centers on the cannabis type and dose to be delivered. The pharmacists with the Department of Health will also be in charge of evaluating data on the forms of medical marijuana available, and the study of the patients and their response to treatment, as well as reviewing the existing scientific data on cannabis.

The program planned for medical marijuana in Minnesota will be a very rigid, structured program for the use of this compound. It is designed to limit the inappropriate use of marijuana for recreational enjoyment. It is also meant to use cannabis as a medication, and to study the patients and its effectiveness in a comprehensive management environment. Hopefully, the program can be implemented and be effective. For now, until more scientific evidence becomes available, chronic pain will not be included in Minnesota’s program.